In partnership with
🐿️ Miffed
Hello {{first_name|Motivated and Miffed Community}},
While Black Friday flashes everywhere, AI is quietly re-shuffling itself. Some players get a shot, others get sidelined, and the “AI wave” might not land where you expect. Let’s separate the noise from what actually matters.
What type of content do you find most valuable?
TL;DR
🌐 Asia’s AI underdogs may get a second chance — investors pull back on U.S. AI hype, opening space for previously ignored firms.
🔬 Medical-imaging AI gets a U.S. rollout — a new partnership brings advanced imaging AI to more hospitals.
📉 Investor optimism stalling — recent survey shows many firms haven’t actually used AI recently, despite boosters saying AI would explode their profits.
The AI Insights Every Decision Maker Needs
You control budgets, manage pipelines, and make decisions, but you still have trouble keeping up with everything going on in AI. If that sounds like you, don’t worry, you’re not alone – and The Deep View is here to help.
This free, 5-minute-long daily newsletter covers everything you need to know about AI. The biggest developments, the most pressing issues, and how companies from Google and Meta to the hottest startups are using it to reshape their businesses… it’s all broken down for you each and every morning into easy-to-digest snippets.
If you want to up your AI knowledge and stay on the forefront of the industry, you can subscribe to The Deep View right here (it’s free!).
🧠 Top 3 AI Stories
The event: As investor frenzy around U.S.-led AI cools, some Asian AI firms — previously dismissed as “also-ran” — are gaining fresh interest.
Why you care: This could mean fewer gatekeepers, more global competition, and a broader set of tools (maybe cheaper, more niche-friendly) for creators.
Creator move (15 min): Scan the top 5 under-the-radar AI startups from Asia. Bookmark ones with creative-tool potential. Might be your next secret weapon.
The event: Avicenna.AI and Ferrum Health announced a partnership to roll out advanced imaging-AI tools across U.S. medical facilities.
Why you care: Big infrastructure can create big shifts — tools built for medicine often spin off into creative/deep-learning pipelines (think dataset prep, medical-video analysis, even generative art).
Creator move (15 min): Sketch a side gig or project idea using imaging-AI (e.g. medical-style B-roll, educational explainers, dataset-driven art). Might ride the wave before early adopters swallow all the yield.
The signal: Government survey & investor-watchdog reports show many companies saying “we plan to use AI” — but few have actually plugged it into operations yet.
Why you care: Means the playing-field stays level for now — it’s not too late to build thoughtful, low-hype, high-value AI workflows.
Creator move (15 min): Audit your next 3 content ideas: can you build them now with current tools? Or are you waiting for “future AI features”? Cut the wait — start with today’s stack.
🔎 Content Gaps & Creator Angles to Exploit
Global AI reset — not just U.S. hype: Few media outlets discuss how cooling U.S. investor interest benefits global smaller players. Turn that into a story.
Medical AI → Creative spin-offs: People see “AI in hospitals,” you see “under-the-hood tech.” Bridge that gap — you get novelty + relevance.
“AI used?” survey angle: Most coverage treats firms saying “we use AI” as a win — reality says otherwise. Use contrast to highlight real tools vs promises.
👋 Outro — No Sales, Just Signals
While the internet screams “50% off!”, the real bargains are hidden in global shifts, AI infrastructure, and slow-burn opportunities.
Pick one small move. Build something today.
Stay MOTIVATED,
Gio